Detalles de la búsqueda
1.
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Lancet Oncol
; 20(2): 267-281, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30579763
2.
The effect, moderators, and mediators of resistance and aerobic exercise on health-related quality of life in older long-term survivors of prostate cancer.
Cancer
; 121(16): 2821-30, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25891302
3.
Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease.
Clin Proteomics
; 12(1): 24, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26388710
4.
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
Lancet Oncol
; 15(10): 1076-89, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25130995
5.
Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer.
BJU Int
; 114(3): 344-53, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24512527
6.
Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials.
Lancet Oncol
; 13(2): 189-95, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22112793
7.
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Lancet Oncol
; 13(12): 1260-70, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23151431
8.
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.
Lancet Oncol
; 12(5): 451-9, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21440505
9.
Relapse patterns after low-dose-rate prostate brachytherapy.
Brachytherapy
; 20(2): 291-295, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33158775
10.
Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial.
Int J Radiat Oncol Biol Phys
; 106(4): 693-702, 2020 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32092343
11.
PSA response signatures - a powerful new prognostic indicator after radiation for prostate cancer?
Radiother Oncol
; 90(3): 382-8, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18992951
12.
A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial.
BMC Cancer
; 9: 419, 2009 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-19951446
13.
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial.
Lancet Oncol
; 9(11): 1058-68, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18929505
14.
Prostate cancer--are ethnic minorities disadvantaged?
Anticancer Res
; 28(6B): 3891-5, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19192646
15.
A prospective audit of the 10-year outcomes from low dose-rate brachytherapy for early stage prostate cancer.
N Z Med J
; 131(1485): 13-18, 2018 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30408814
16.
Prostate cancer: the new evidence base for diagnosis and treatment.
Pathology
; 39(6): 537-44, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18027255
17.
Proteins Annexin A2 and PSA in Prostate Cancer Biopsies Do Not Predict Biochemical Failure.
Anticancer Res
; 37(12): 6943-6946, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29187477
18.
Intensity-modulated radiotherapy in the treatment of locoregionally advanced head and neck cancer: implementation and outcomes in a New Zealand community hospital.
J Med Radiat Sci
; 63(2): 96-103, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27350889
19.
Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial.
Radiother Oncol
; 121(1): 98-102, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27528117
20.
Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial.
Radiother Oncol
; 115(3): 301-7, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26072289